Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.
Saved in:
| Title: | Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status. |
|---|---|
| Authors: | Førde D; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Kilvær T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Pedersen MI; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Lombardi AP; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway., D'arsiè I; Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy., Paulsen EE; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Busund LR; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Rakaee M; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Dønnem T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Andersen S; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. Date of Electronic Publication: 2025 Sep 25 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41079079 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Førde+D%22">Førde D</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Kilvær+T%22">Kilvær T</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Pedersen+MI%22">Pedersen MI</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Lombardi+AP%22">Lombardi AP</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22D'arsiè+I%22">D'arsiè I</searchLink>; Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Paulsen+EE%22">Paulsen EE</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Busund+LR%22">Busund LR</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Rakaee+M%22">Rakaee M</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Dønnem+T%22">Dønnem T</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Andersen+S%22">Andersen S</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. <i>Date of Electronic Publication: </i>2025 Sep 25 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41079079 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1606933 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1606933 Titles: – TitleFull: Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Førde D – PersonEntity: Name: NameFull: Kilvær T – PersonEntity: Name: NameFull: Pedersen MI – PersonEntity: Name: NameFull: Lombardi AP – PersonEntity: Name: NameFull: D'arsiè I – PersonEntity: Name: NameFull: Paulsen EE – PersonEntity: Name: NameFull: Busund LR – PersonEntity: Name: NameFull: Rakaee M – PersonEntity: Name: NameFull: Dønnem T – PersonEntity: Name: NameFull: Andersen S IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 09 Text: 2025 Sep 25 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |